Award

EderaGen AS won the prize as the Most Innovative Gut Health-Focused BioTech Company – Northern Europe at the 2023 Biotechnology Awards, hosted by Global Health & Pharma (GHP). The presentation in the GHP Magazine states:

Norwegian company, EderaGen is disrupting our perception of gut health by getting back to nature. Based on ecological principles, EderaGen develops products designed to strengthen the innate immune system by balancing the microbial community in the human gut. We take a look at the company and its award-winning concept with founder and CEO, Knut Eirik Andersen.

The full page article about EderaGen AS can be read here.

The GHP programme has been running for eight consecutive years. It acknowledges leading pioneers and technology developers across the globe, and by means of the Biotechnology Awards it looks to highlight businesses that are keeping their fingers on the pulse and inventing new ways to further advance in the field of biotechnology.